Tag

Travel News

29/11/2018
,

World Malaria Report 2018

We have just had the opportunity to digest the latest World Health Organisations report on Malaria, and it makes for some interesting reading. In 2017 there were a reported 219 million cases of malaria worldwide compared with 239 million cases in 2010. Whilst it is great news that we have seen a reduction, it is a stark reminder that malaria is present and the global disease burden is still present. Despite significant amounts of money being invested (upwards of $3.1 billion) in the eradication of malaria, significant progress has not been... Read More

20/08/2018

Hong Kong, Pakistan and Vietnam Hit By Dengue Fever.

It’s time for another Dengue travel update. So what has changed? Travelling to a tropical part of the world? Then Dengue may be a problem for you. We produced a blog some years ago on the disease, how is spread and what you can do to prevent it.  The disease hasn’t changed in this time and neither have the destinations, but the purpose of this is to highlight ongoing outbreaks: Hong Kong The current outbreak in Lion Rock Park.  Lion Rock Park is a popular destination on the edge of... Read More

18/06/2018

Travel Health News Weekly Roundup (June 11th – 17th 2018)

It’s that time again for your Travelpharm weekly health news roundup! We have collected all the latest news articles from around the world to get you up-to-date with all the breaking travel health news. It is always important to do your research when planning to travel abroad. The more you know before you travel, the better prepared you will be once you’re there. Allowing you to enjoy your holiday without worrying about unexpected surprises. The following articles are for 11-17 June 2018. Enjoy! Rabies Vaccinations Its been reported that Global... Read More

17/01/2018

NEWS: Sanofi Reimburse Unused Dengue Fever Vaccines

Sanofi set to reimburse the Philippines Government for unused doses of a new Dengue Fever vaccine. The worlds first dengue vaccine Dengvaxi (CDT-TDV) by Sanofi Pasteur was registered in Mexico in December 2015. It was indicated for nationals living in areas with high disease burden between the ages of 9-45 years of age. The product has passed many clinical trials worldwide and is registered for use with 19 regulatory authorities worldwide. Two of these authorities, Brazil and the Philippines, introduced the vaccine into subnational programmes, targeting approximately 1 million individuals.... Read More

15/01/2018

NEWS: New Conjugate Typhoid Vaccine Is Awarded WHO Prequalification

WHO to take a big step forward in the fight against Typhoid. An Indian bioresearch company has now been granted World Health Organisation pre-qualification for their product Typbar-TCV.  Typbar-TCV is a conjugate vaccine.  Conjugate vaccines offer longer and stronger immunity over their polysaccharide cousins and its product has been demonstrated safe in populations as young as 6 months. Until now countries endemic with Typhoid fever, which is a bacterial infection caused by Salmonella, have relied on an old polysaccharide vaccine.  The current polysaccharide vaccine can only be used from 2... Read More

12/01/2018

NEWS: WHO Supports Immunisation Against Cholera In Zambia

Following an outbreak of cholera in Zambia’s capital, 1 million residents of Lusaka are set to be immunised against the deadly disease. The outbreak initially started in the Chipata sub-district on the 2nd October 2017, where it continued to spread leading to the Minister of Health to declare an outbreak on the 6th October¹. On the 9th of January 2018 the Zambian Government placed a temporary suspension on the issue of passports and national identity cards in a bid to contain the disease².  It is only now that the Zambian government... Read More